Deal Team

Corporate

Pacira BioSciences in its response to a proxy fight by DOMA Perpetual Capital Management

On March 14, 2025, Pacira BioSciences, Inc. confirmed that DOMA Perpetual Capital Management LLC has nominated three candidates to stand for election to the Pacira Board of Directors at the Company’s 2025 Annual Meeting.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Pacira BioSciences.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.